James Shin
Stock Analyst at Deutsche Bank
(2.67)
# 1,904
Out of 5,154 analysts
24
Total ratings
54.55%
Success rate
20.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,200 → $1,285 | $990.33 | +29.75% | 6 | Feb 9, 2026 | |
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $115.79 | -4.14% | 3 | Nov 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $9.86 | +1.42% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $143.93 | -16.63% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $369.53 | -17.46% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $95.94 | -37.46% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $60.29 | -25.36% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $18.97 | +216.29% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $230.11 | -34.81% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $759.86 | +5.28% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.51 | +562.25% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $25.29 | +374.50% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Feb 9, 2026
Maintains: Buy
Price Target: $1,200 → $1,285
Current: $990.33
Upside: +29.75%
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $115.79
Upside: -4.14%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $9.86
Upside: +1.42%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $143.93
Upside: -16.63%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $369.53
Upside: -17.46%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $95.94
Upside: -37.46%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $60.29
Upside: -25.36%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $18.97
Upside: +216.29%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $230.11
Upside: -34.81%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $759.86
Upside: +5.28%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Nov 9, 2023
Initiates: Buy
Price Target: $120
Current: $25.29
Upside: +374.50%